TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress

Biochemical and Biophysical Research Communications

Volumn 440, Issue 2, 2013, Pages 336-341

  Maier, Olaf ^a   Fischer, Roman ^a   Agresti, Cristina ^b   Pfizenmaier, Klaus ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Apoptosis; CD120b; Oligodendroglia; Tumor necrosis factor

Indexed keywords

SUPEROXIDE DISMUTASE; TENASCIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL FUNCTION; CONTROLLED STUDY; FOREBRAIN; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TRANSGENIC MOUSE;

2′,3′-CYCLIC NUCLEOTIDE 3′-PHOSPHODIESTERASE; APOPTOSIS; CD120B; CENTRAL NERVOUS SYSTEM; CNP; CNS; EAE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MBP; MS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; OLG; OLIGODENDROCYTE; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; OPC; PLL; PLP; POLY-L-LYSINE; PROTEOLIPID PROTEIN; SCTNF(R2); SINGLE CHAIN TNF SPECIFIC FOR TNFR2; SOD; SUPEROXIDE DISMUTASE; TENASCIN C; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE DUTP NICK END LABELING; TNC; TNF; TNFR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUNEL;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; OLIGODENDROGLIA; OXIDATIVE STRESS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STEM CELLS;

MUS MUSCULUS;

EID: 84885871778     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.083     Document Type: Article

References (38)

1. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45-65.
2. Hofman F.M., Hinton D.R., Johnson K., Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 1989, 170:607-612.
3. Selmaj K., Raine C.S., Cannella B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 1991, 87:949-954.
4. TNF neutralization in MS: results of a randomized, placebocontrolled multicenter study. Neurology 1999, 53:457-465. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
5. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflamm. 2008, 17:5-45.
6. Faustman D., Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat. Rev. Drug Discov. 2010, 9:482-493.
7. Marchetti L., Klein M., Schlett K., Pfizenmaier K., Eisel U. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-κB pathway. J. Biol. Chem. 2004, 279:32869-32881.
8. Dolga A.M., Granic I., Blank T., Knaus H.G., Spiess J., et al. TNF-α mediates neuroprotection against glutamate-induced excitotoxicity via NF-κB-dependent up-regulation of K2.2 channels. J. Neurochem. 2008, 107:1158-1167.
9. Fischer R., Maier O., Siegemund M., Wajant H., Scheurich P., Pfizenmaier K. A TNF receptor 2 selective agonist rescues neurons from oxidative stress induced cell death. PLoS One 2011, 6:e27621.
10. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 2002, 22:RC216.
11. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4:1116-1122.
12. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., et al. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendropathy. Am. J. Pathol. 1998, 153:801-813.
13. Grell M., Douni E., Wajant H., Löhden M., Clauss M., et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor. Cell 1995, 83:793-802.
14. Brambilla R., Ashbaugh J.J., Magliozzi R., Dellarole A., Karmally S., et al. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 2011, 134:2736-2754.
15. Taoufik E., Tseveleki V., Euagelidou M., Emmanouil M., Voulgari-Kokota A., et al. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis. Neurodegener. Dis. 2008, 5:32-37.
16. Hisahara S., Shoji S., Okano H., Miura M. ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J. Neurochem. 1997, 69:10-20.
17. Jurewicz A., Matysiak M., Tybor K., Kilianek L., Raine C.S., Selmaj K. Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 2005, 128:2675-2688.
18. Pang Y., Cai Z., Rhodes P.G. Effect of tumor necrosis factor-α on developing optic nerve oligodendrocytes in culture. J. Neurosci. Res. 2005, 80:226-234.
19. Su Z., Yuan Y., Chen J., Zhu Y., Qiu Y., et al. Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-α. J. Neurotrauma 2011, 28:1089-1100.
20. Hövelmeyer N., Hao Z., Kranidioti K., Kassiotis G., Buch T., et al. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 2005, 175:5875-5884.
21. Kim S., Steelman A.J., Koito H., Li J. Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors. J. Neurochem. 2010, 116:53-66.
22. Tchélingérian J.L., Monge M., Le Saux F., Zalc B., Jacque C. Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J. Neurochem. 1995, 65:2377-2380.
23. Wilt S., Milward E., Zhou J., Nagasato K., Patton H., et al. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type I encephalopathy. Ann. Neurol. 1995, 37:294-382.
24. Douni E., Kollias G. A critical role of the p75 tumor necrosis factor receptor (p75-TNFR) in organ inflammation independent of TNF, lymphotoxin α or the p55-TNRFR. J. Exp. Med. 1998, 188:1343-1352.
25. Bottenstein J.E., Sato G.H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 1979, 76:514-517.
26. Rauert H., Wicovsky A., Müller N., Siegmund D., Spindler V., et al. Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J. Biol. Chem. 2010, 285:7394-7404.
27. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980, 85:890-902.
28. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
29. Kleinbongard P., Schulz R., Heusch G. TNFα in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail. Rev. 2011, 16:49-69.
30. Veroni C., Gabriele L., Canini I., Castiello L., Coccia E., et al. Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways. Mol. Cell. Neurosci. 2010, 45:234-244.
31. Epperly M.W., Sikora C.A., DeFilippi S.J., Gretton J.A., Zhan Q., et al. Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membrane. Radiat. Res. 2002, 157:568-577.
32. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The BCL-2 family reunion. Mol. Cell 2010, 12:299-310.
33. Sloane L., Cho H.J., Niculescu F., Rus H., Shin M.L. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J. Immunol. 2001, 167:2305-2311.
34. Baud O., Haynes R.F., Wang H., Folkerth R.D., Li J., et al. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur. J. Neurosci. 2004, 20:29-40.
35. Fischer R., Maier O., Naumer M., Krippner-Heidenreich A., Scheurich P., Pfizenmaier K. Ligand induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway. Cell. Signal. 2011, 23:161-170.
36. Flores A.I., Mallon B.S., Matsui T., Ogawa W., Rosenzweig A., et al. Akt-mediated survival of oligodendrocytes induced by neuregulins. J. Neurosci. 2000, 15:7622-7630.
37. Hamanoue M., Yoshioka A., Ohashi T., Eto Y., Takamatsu K. NF-kappaB prevents TNF-alpha-induced apoptosis in an oligodendrocyte cell line. Neurochem. Res. 2004, 29:1571-1576.
38. Pang Y., Zheng B., Fan L.W., Rhodes P.G., Cai Z. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of mitochondrial apoptotic pathway. Glia 2007, 55:1099-1107.